Amicus Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
29.09.23
/
50%
€11.70
Target price
29.09.24
€17.92
Performance (%)
-19.23%
End price
30.09.24
€9.45
Summary
This prediction ended on 30.09.24 with a price of €9.45. The price of Amicus Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.23%. JPMorgan_Chase___Co_ has a follow-up prediction for Amicus Therapeutics Inc. where he still thinks Amicus Therapeutics Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | 0.000% | 0.000% | 35.556% |
| iShares Core DAX® | 0.191% | 4.771% | 20.559% |
| iShares Nasdaq 100 | -0.614% | 3.137% | 5.816% |
| iShares Nikkei 225® | 0.599% | 8.016% | 21.913% |
| iShares S&P 500 | -0.036% | 3.593% | 3.588% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at JPMorgan Chase & Co. from $17.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.65
06.11.25
06.11.25
€16.51
06.11.26
06.11.26
60.78%
16.01.26
16.01.26
Stopped prediction by JPMorgan_Chase___Co_ for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.85
12.11.24
12.11.24
€16.03
12.11.25
12.11.25
-18.27%
13.11.25
13.11.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.40
16.08.24
16.08.24
€14.55
16.08.25
16.08.25
-39.90%
17.08.25
17.08.25